Back to Results
First PageMeta Content
Ribbon symbolism / Alkenes / AstraZeneca / Tamoxifen / Exemestane / Breast cancer / Adjuvant therapy / Menopause / Ovarian cancer / Medicine / Pharmacology / Aromatase inhibitors


landmarks Breast cancer: ovarian function suppression The SOFT trial Victoria Mandilaras, MD, Resident; Nathaniel Bouganim, MD, Medical Oncologist; Jamil Asselah, MD, Medical Oncologist, McGill University Health Centre a
Add to Reading List

Document Date: 2015-03-04 15:16:37


Open Document

File Size: 1,09 MB

Share Result on Facebook

City

San Antonio / /

Company

E+OFS / Fleming / ZIPP International Collaborators Group / Eastern Cooperative Oncology Group / T+OFS / Baum M / /

IndustryTerm

treatment of breast cancer / /

MedicalCondition

hormone receptor-positive breast cancer / early-stage breast cancer / hypertension / cancer / osteoporosis / breast cancer-free interval / larger tumours / higher-risk tumours / early breast cancer / depression / Breast Cancer / tumour / significantly more vaginal discharge / landmarks Breast cancer / J Cancer / early-stage ER+ breast cancer / tumours / /

MedicalTreatment

chemotherapy / surgery / adjuvant chemotherapy / endocrine therapy / radiation / adjuvant therapy / /

Organization

McGill University Health Centre / /

Person

Jamil Asselah / Victoria Mandilaras / Nathaniel Bouganim / /

Product

exemestane / Trelstar / estradiol / /

Technology

radiation / chemotherapy / /

SocialTag